Molecular-Level Control of Ciclopirox Olamine Release from Poly(ethylene oxide)-Based Mucoadhesive Buccal Films: Exploration of Structure-Property Relationships with Solid-State NMR
Language English Country United States Media print-electronic
Document type Journal Article
- Keywords
- PEO, ciclopirox olamine, mucoadhesive buccal films, polymer−drug interactions, polymorphism, solid state NMR,
- MeSH
- Adhesives chemistry metabolism MeSH
- Biological Availability MeSH
- Chemistry, Pharmaceutical methods MeSH
- Ciclopirox MeSH
- Ethylene Oxide chemistry MeSH
- Crystallization methods MeSH
- Magnetic Resonance Spectroscopy methods MeSH
- Nanoparticles chemistry MeSH
- Oral Mucosal Absorption physiology MeSH
- Polyethylene Glycols chemistry metabolism MeSH
- Polymers chemistry MeSH
- Pyridones chemistry MeSH
- Solubility MeSH
- Mouth Mucosa metabolism MeSH
- Drug Liberation physiology MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Adhesives MeSH
- Ciclopirox MeSH
- Ethylene Oxide MeSH
- Polyethylene Glycols MeSH
- Polymers MeSH
- Pyridones MeSH
Mucoadhesive buccal films (MBFs) provide an innovative way to facilitate the efficient site-specific delivery of active compounds while simultaneously separating the lesions from the environment of the oral cavity. The structural diversity of these complex multicomponent and mostly multiphase systems as well as an experimental strategy for their structural characterization at molecular scale with atomic resolution were demonstrated using MBFs of ciclopirox olamine (CPX) in a poly(ethylene oxide) (PEO) matrix as a case study. A detailed description of each component of the CPX/PEO films was followed by an analysis of the relationships between each component and the physicochemical properties of the MBFs. Two distinct MBFs were identified by solid-state NMR spectroscopy: (i) at low API (active pharmaceutical ingredient) loading, a nanoheterogeneous solid solution of CPX molecularly dispersed in an amorphous PEO matrix was created; and (ii) at high API loading, a pseudoco-crystalline system containing CPX-2-aminoethanol nanocrystals incorporated into the interlamellar space of a crystalline PEO matrix was revealed. These structural differences were found to be closely related to the mechanical and physicochemical properties of the prepared MBFs. At low API loading, the polymer chains of PEO provided sufficient quantities of binding sites to stabilize the CPX that was molecularly dispersed in the highly amorphous semiflexible polymer matrix. Consequently, the resulting MBFs were soft, with low tensile strength, plasticity, and swelling index, supporting rapid drug release. At high CPX content, however, the active compounds and the polymer chains simultaneously cocrystallized, leaving the CPX to form nanocrystals grown directly inside the spherulites of PEO. Interfacial polymer-drug interactions were thus responsible not only for the considerably enhanced plasticity of the system but also for the exclusive crystallization of CPX in the thermodynamically most stable polymorphic form, Form I, which exhibited reduced dissolution kinetics. The bioavailability of CPX olamine formulated as PEO-based MBFs can thus be effectively controlled by inducing the complete dispersion and/or microsegregation and nanocrystallization of CPX olamine in the polymer matrix. Solid-state NMR spectroscopy is an efficient tool for exploring structure-property relationships in these complex pharmaceutical solids.
References provided by Crossref.org